Retail investors account for 57% of Service Stream Limited's (ASX:SSM) ownership, while institutions account for 36%
43% of the business is held by the top 25 shareholders
Institutions own 36% of Service Stream
A look at the shareholders of Service Stream Limited (ASX:SSM) can tell us which group is most powerful. With 57% stake, retail investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
Meanwhile, institutions make up 36% of the company's shareholders. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders.
In the chart below, we zoom in on the different ownership groups of Service Stream.
See our latest analysis for Service Stream
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
We can see that Service Stream does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Service Stream's historic earnings and revenue below, but keep in mind there's always more to the story.
We note that hedge funds don't have a meaningful investment in Service Stream. Orbis Investment Management Limited is currently the company's largest shareholder with 6.9% of shares outstanding. With 5.1% and 5.0% of the shares outstanding respectively, Pinnacle Investment Management Group Limited and The Vanguard Group, Inc. are the second and third largest shareholders.
Our studies suggest that the top 25 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.
Shareholders would probably be interested to learn that insiders own shares in Service Stream Limited. In their own names, insiders own AU$52m worth of stock in the AU$1.1b company. This shows at least some alignment. You can click here to see if those insiders have been buying or selling.
The general public, who are usually individual investors, hold a substantial 57% stake in Service Stream, suggesting it is a fairly popular stock. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.
It's always worth thinking about the different groups who own shares in a company. But to understand Service Stream better, we need to consider many other factors. To that end, you should be aware of the 1 warning sign we've spotted with Service Stream .
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
40 minutes ago
- Yahoo
Temple & Webster Group Full Year 2025 Earnings: Revenues In Line With Expectations
Temple & Webster Group (ASX:TPW) Full Year 2025 Results Key Financial Results Revenue: AU$600.7m (up 21% from FY 2024). Net income: AU$11.3m (up by AU$9.51m from FY 2024). Profit margin: 1.9% (up from 0.4% in FY 2024). The increase in margin was driven by higher revenue. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Temple & Webster Group Meets Expectations Revenue was in line with analyst estimates. In the last 12 months, the only revenue segment was The Sale of Furniture, Homewares and Home Improvement Products contributing AU$600.7m. Notably, cost of sales worth AU$444.0m amounted to 74% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to AU$115.7m (79% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of AU$900.0k. Explore how TPW's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Specialty Retail industry in Australia. Performance of the Australian Specialty Retail industry. The company's shares are down 3.8% from a week ago. Balance Sheet Analysis While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. See our latest analysis on Temple & Webster Group's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
12 hours ago
- Yahoo
August 2025's Promising Penny Stocks In Global Market
As global markets navigate a landscape marked by interest rate adjustments and shifting trade dynamics, investors are keenly observing the opportunities that arise amidst these changes. Penny stocks, often seen as relics of earlier market days, still hold relevance by offering exposure to smaller or newer companies with potential for growth. By identifying those with strong financials and promising outlooks, investors can find compelling opportunities in this segment of the market. Top 10 Penny Stocks Globally Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$2.39 A$109.91M ★★★★★★ Lever Style (SEHK:1346) HK$1.47 HK$915.41M ★★★★★★ GTN (ASX:GTN) A$0.405 A$74.36M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.49 HK$2.1B ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ MGB Berhad (KLSE:MGB) MYR0.505 MYR298.78M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Zetrix AI Berhad (KLSE:ZETRIX) MYR0.90 MYR6.92B ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.155 £183.58M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.934 €31.5M ★★★★★★ Click here to see the full list of 3,784 stocks from our Global Penny Stocks screener. Let's uncover some gems from our specialized screener. Goldpac Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Goldpac Group Limited is an investment holding company that offers embedded software, secure payment products, and smart financial self-service kiosks in Mainland China and internationally, with a market cap of HK$918.61 million. Operations: The company's revenue is derived from two main segments: Platform and Service, generating CN¥472.94 million, and Embedded Software and Secure Payment Products, contributing CN¥622.36 million. Market Cap: HK$918.61M Goldpac Group Limited, with a market cap of HK$918.61 million, is experiencing challenges as its revenue and profit are expected to decline by 10%-20% and 20%-30% respectively for the first half of 2025 compared to the previous year. Despite being debt-free and having high-quality earnings, the company's return on equity is low at 2.5%, and its profit margins have decreased from last year's figures. The management team is experienced with an average tenure of nine years, but recent board changes may impact strategic direction. The stock trades significantly below estimated fair value but faces unstable dividend records. Dive into the specifics of Goldpac Group here with our thorough balance sheet health report. Assess Goldpac Group's previous results with our detailed historical performance reports. ValueMax Group Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: ValueMax Group Limited, with a market cap of SGD729.63 million, operates in Singapore focusing on pawnbroking, moneylending, jewelry and watches retailing, and gold trading businesses. Operations: There are no specific revenue segments reported for the company. Market Cap: SGD729.63M ValueMax Group Limited, with a market cap of SGD729.63 million, reported strong half-year earnings growth, with sales reaching SGD 268.34 million and net income at SGD 48.03 million, both up from the previous year. Despite high-quality earnings and improved profit margins (19.3%), the company's operating cash flow remains negative, impacting debt coverage and dividend sustainability (3.44%). While its short-term assets significantly exceed liabilities, indicating solid liquidity management, ValueMax's net debt to equity ratio is high at 126.2%. The stock trades below fair value estimates but benefits from experienced management and board teams. Take a closer look at ValueMax Group's potential here in our financial health report. Learn about ValueMax Group's historical performance here. Huapont Life SciencesLtd Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Huapont Life Sciences Co., Ltd. operates in the fields of medicine, medical care, agrochemicals, new materials, and tourism both in China and internationally with a market cap of CN¥8.74 billion. Operations: Huapont Life Sciences Co., Ltd. has not reported specific revenue segments, but it operates across various sectors including medicine, medical care, agrochemicals, new materials, and tourism both domestically and internationally. Market Cap: CN¥8.74B Huapont Life Sciences Co., Ltd., with a market cap of CN¥8.74 billion, operates across diverse sectors but remains unprofitable, facing challenges in earnings growth and profitability. The management team is experienced, with an average tenure of 11.6 years, and the board also brings seasoned expertise. Despite its financial struggles, the company has managed to reduce its debt to equity ratio from 82.6% to 59.7% over five years and maintains satisfactory net debt levels at 31.6%. Recent changes include amendments to company bylaws and the election of Zhang Songshan as a non-independent director. Get an in-depth perspective on Huapont Life SciencesLtd's performance by reading our balance sheet health report here. Understand Huapont Life SciencesLtd's track record by examining our performance history report. Seize The Opportunity Gain an insight into the universe of 3,784 Global Penny Stocks by clicking here. Searching for a Fresh Perspective? We've found 19 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:3315 SGX:T6I and SZSE:002004. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 hours ago
- Yahoo
ASX Penny Stocks Spotlight: Archer Materials And Two More Top Picks
As the Australian market wraps up a week of modest gains, investors are reflecting on the Reserve Bank's recent rate cut and its limited impact on trading sentiment. In this context, penny stocks—often smaller or newer companies—remain an intriguing option for those looking to explore beyond the more established names. While the term might seem outdated, these stocks continue to offer potential value through affordability and growth opportunities when backed by solid financials. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$2.33 A$109.91M ★★★★★★ GTN (ASX:GTN) A$0.39 A$74.36M ★★★★★★ IVE Group (ASX:IGL) A$2.95 A$454.84M ★★★★★☆ West African Resources (ASX:WAF) A$2.73 A$3.11B ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.99 A$526.17M ★★★★★★ Regal Partners (ASX:RPL) A$3.08 A$1.04B ★★★★★★ Bravura Solutions (ASX:BVS) A$1.91 A$856.25M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.355 A$129.75M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$4.50 A$213.53M ★★★★★★ CTI Logistics (ASX:CLX) A$1.795 A$144.58M ★★★★☆☆ Click here to see the full list of 454 stocks from our ASX Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Archer Materials Simply Wall St Financial Health Rating: ★★★★★★ Overview: Archer Materials Limited is an Australian technology company focused on developing and commercializing semiconductor devices and sensors for quantum computing and medical diagnostics, with a market cap of A$89.20 million. Operations: The company generates revenue from its Materials Technology Research and Development segment, amounting to A$2.31 million. Market Cap: A$89.2M Archer Materials, with a market cap of A$89.20 million, is pre-revenue and currently unprofitable, generating limited revenue of A$2.31 million from its R&D segment. The company benefits from a strong liquidity position, with short-term assets (A$18.9M) surpassing both short-term (A$621.4K) and long-term liabilities (A$29K), and is debt-free for the past five years. While earnings have declined at 18.3% annually over the past five years, Archer maintains a stable cash runway exceeding three years based on current free cash flow levels without significant shareholder dilution recently observed. Navigate through the intricacies of Archer Materials with our comprehensive balance sheet health report here. Assess Archer Materials' previous results with our detailed historical performance reports. Genesis Minerals Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Genesis Minerals Limited is involved in the exploration, production, and development of gold deposits in Western Australia, with a market cap of A$4.77 billion. Operations: The company generates revenue of A$561.40 million from its mineral production, exploration, and development activities in Western Australia. Market Cap: A$4.77B Genesis Minerals, with a market cap of A$4.77 billion, has recently achieved profitability and boasts high-quality earnings. The company's debt is well-covered by operating cash flow, and it holds more cash than total debt, indicating strong financial health. Short-term assets comfortably exceed both short-term and long-term liabilities. Despite a relatively new board with an average tenure of 2.8 years, recent executive changes include the appointment of Jane Macey as Non-Executive Director, bringing over 20 years of industry experience. Genesis trades slightly below its estimated fair value and maintains stable weekly volatility at 6%. Unlock comprehensive insights into our analysis of Genesis Minerals stock in this financial health report. Understand Genesis Minerals' earnings outlook by examining our growth report. Pantoro Gold Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Pantoro Gold Limited, with a market cap of A$1.69 billion, is involved in gold mining, processing, and exploration activities in Western Australia through its subsidiaries. Operations: The company generates revenue from its Norseman Gold Project, amounting to A$289.11 million. Market Cap: A$1.69B Pantoro Gold Limited, with a market cap of A$1.69 billion, remains unprofitable but has a solid financial position with short-term assets (A$128.9M) exceeding both short and long-term liabilities. The company has more cash than total debt and maintains a sufficient cash runway for over three years, even as its free cash flow shrinks by 23.6% annually. Despite increasing losses over the past five years at 32% per year, earnings are forecast to grow significantly at 58.69% per year. The management team is experienced with an average tenure of 10.8 years, providing stability amid financial challenges. Click here to discover the nuances of Pantoro Gold with our detailed analytical financial health report. Examine Pantoro Gold's earnings growth report to understand how analysts expect it to perform. Key Takeaways Reveal the 454 hidden gems among our ASX Penny Stocks screener with a single click here. Ready To Venture Into Other Investment Styles? Outshine the giants: these 18 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:AXE ASX:GMD and ASX:PNR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data